Clinical Trials Arena on MSN
Thermo Fisher Scientific acquires Clario for nearly $8.9bn
Clario will become part of Thermo Fisher’s laboratory products and biopharma services segment.
RIDGEFIELD, N.J.-- (BUSINESS WIRE)--Mar 25, 2026-- ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the completion of its acquisition of Clario Holdings, Inc., a leading provider of endpoint data ...
Thermo Fisher Scientific has completed its acquisition of Clario Holdings for $8.875 billion in cash, plus potential ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the Best Conservative Stocks to Buy Right Now. On March 24, the company ...
FRANKFURT, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest flexible solutions to help boost efficiency and scale in ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts.
Emerald Wealth Partners, an independent asset and wealth management firm based in Zurich, released its Q4 2025 investor letter for the “Growth Equity Strategy.” A copy of the letter is available to ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of Goldman Sachs top healthcare stocks. On March 3 at the 47th Annual Raymond ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results